Mark Levine, MD
Ontario Clinical Oncology Group (OCOG) · ocog · Ontario Clinical Oncology Group/McMaster University, Department of Oncology
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
17
all conditions, ClinicalTrials.gov
NIH grants tied to them
1
NIH RePORTER
Trial papers in non-small cell lung cancer
0
PubMed author-name match
Trials
Studies that name Mark Levine, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:38 UTC. Open this list on ClinicalTrials.gov
- N/ANCT02751710 · Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast CancerOntario Clinical Oncology Group (OCOG) · completed · Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4), Stage IIb Breast Cancer (T3N0) · study director
- N/ANCT02462239 · Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder StagingOntario Clinical Oncology Group (OCOG) · completed · Muscle-invasive Bladder Cancer · study director
- N/ANCT02038530 · The Designer D-dimer Deep Vein Thrombosis Diagnosis (4D) StudyMcMaster University · completed · Suspected Deep Vein Thrombosis · study director
- Ph2NCT01769547 · A Phase II Study of Single-agent DOVitinib in Advanced Malignant PlEural Mesothelioma Which Has Progressed Following Prior Platinum-Antifolate ChemotherapyOntario Clinical Oncology Group (OCOG) · terminated · Advanced Malignant Pleural Mesothelioma, MPM · study director
- Ph2NCT01678105 · A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary GlandsOntario Clinical Oncology Group (OCOG) · completed · Recurrent Adenoid Cystic Carcinoma of the Salivary Glands, Metastatic Adenoid Cystic Carcinoma of the Salivary Glands, Salivary Gland Cancers · study director
- N/ANCT00895349 · Impact of Positron Emission Tomography (PET) Imaging in Women With Locally Advanced Cervical Cancer (PET LACE Trial)Ontario Clinical Oncology Group (OCOG) · completed · Cervical Cancer, Squamous Cell Carcinoma, Adenosquamous Carcinoma · study director
- N/ANCT00686465 · Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility StudyOntario Clinical Oncology Group (OCOG) · completed · Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer · study director
- Ph3NCT00310232 · Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)Ontario Clinical Oncology Group (OCOG) · terminated · Non-Small-Cell Lung Carcinoma, Lung Cancer, Anemia · study director
- Ph3NCT00304759 · PROFIT - Prostate Fractionated Irradiation TrialOntario Clinical Oncology Group (OCOG) · completed · Prostate Cancer · study director
- N/ANCT00282035 · RAPID: Randomized Trial of Accelerated Partial Breast IrradiationOntario Clinical Oncology Group (OCOG) · completed · Breast Cancer · study director
- Ph3NCT00265356 · Impact of Positron Emission Tomography Imaging Prior to Liver Resection for Colorectal Adenocarcinoma MetastasesOntario Clinical Oncology Group (OCOG) · completed · Colorectal Cancer, Liver Metastases · principal investigator
- Ph2NCT00239980 · Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)Ontario Clinical Oncology Group (OCOG) · completed · Ovarian Cancer · principal investigator
- Ph3NCT00201916 · Shorter Radiation Schedule for the Treatment of Prostate CancerOntario Clinical Oncology Group (OCOG) · completed · Prostate Cancer · principal investigator
- N/ANCT00201903 · The Roles of Tissue Factor in Malignant GliomasOntario Clinical Oncology Group (OCOG) · completed · Venous Thromboembolism, Brain Tumors · principal investigator
- Ph4NCT00156039 · Randomized Trial of Follow-up Strategies in Breast CancerOntario Clinical Oncology Group (OCOG) · completed · Breast Cancer · principal investigator
- Ph3NCT00156026 · Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1Ontario Clinical Oncology Group (OCOG) · completed · Cervical Intraepithelial Neoplasia · principal investigator
- Ph3NCT00135876 · Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour PatientsOntario Clinical Oncology Group (OCOG) · completed · Venous Thromboembolism, Brain Tumors · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Programmatic Meeting for Surveillance, Epidemiology, and End Results (SEER) - Wisconsin Dept Health Sciences26120180001 · NCI · WISCONSIN DEPARTMENT OF HEALTH SERVICES · fiscal years 2018 · $1,208 awarded in 2018Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.